Science in Action: Wellness in the Workplace with Genetic Testing
Personalized Medicine Conference spotlights Coriell Life Sciences’ medication risk management program
At the annual Personalized Medicine Conference in Boston held November 13-14, Coriell Life Sciences President and CEO Scott Megill joined Jane Cheshire Gilbert, director of retiree healthcare for the Teachers’ Retirement System (TRS) Kentucky to discuss implementing a medication risk management program among the TRS Kentucky pension fund’s 36,000 Medicare-eligible retirees. Administered by Coriell Life Sciences, this comprehensive program driven by genetic testing helped the pension fund to dramatically improve retirees’ health, reduce adverse drug reactions, and lower overall costs.
An online story by GenomeWeb spotlighted panel participants —including Color Genomics and Thomas Jefferson University Hospitals— who addressed the opportunities and challenges of launching employer-sponsored genetic testing partnerships. These pioneers are among the first in the nation to explore cost-effective business models, and questions around ethics, security, and privacy associated with implementing genetic testing programs for healthy people.
Read the GenomeWeb story by Turna Ray
About Coriell Life Sciences
Coriell Life Sciences delivers the power of precision medicine. We are a trusted bioinformatics company that bridges the gap between genetic knowledge and clinical application to drive cost-effective healthcare solutions for laboratories, payers, systems, providers, and patients. Coriell Life Sciences sets the gold standard in genetic interpretation and reporting and offers the most comprehensive medication safety program on the market. Visit coriell.com, email [email protected], or follow @CoriellLife.
–– ### ––
Original post https://alertarticles.info